- Home
- CALC vs BGI Comparison
CALC vs BGI Comparison
Compare CALC & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- BGI
- Stock Information
- Founded
- CALC 2011
- BGI 1879
- Country
- CALC United States
- BGI Canada
- Employees
- CALC N/A
- BGI 290
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- CALC Health Care
- BGI
- Exchange
- CALC Nasdaq
- BGI Nasdaq
- Market Cap
- CALC 26.7M
- BGI 18.0M
- IPO Year
- CALC N/A
- BGI 2005
- Fundamental
- Price
- CALC $1.74
- BGI $0.83
- Analyst Decision
- CALC Strong Buy
- BGI
- Analyst Count
- CALC 3
- BGI 0
- Target Price
- CALC $16.33
- BGI N/A
- AVG Volume (30 Days)
- CALC 22.8K
- BGI 55.0K
- Earning Date
- CALC 05-14-2025
- BGI 07-15-2025
- Dividend Yield
- CALC N/A
- BGI N/A
- EPS Growth
- CALC N/A
- BGI N/A
- EPS
- CALC N/A
- BGI N/A
- Revenue
- CALC N/A
- BGI $131,596,265.00
- Revenue This Year
- CALC N/A
- BGI N/A
- Revenue Next Year
- CALC N/A
- BGI N/A
- P/E Ratio
- CALC N/A
- BGI N/A
- Revenue Growth
- CALC N/A
- BGI 4.01
- 52 Week Low
- CALC $1.43
- BGI $0.76
- 52 Week High
- CALC $5.97
- BGI $2.99
- Technical
- Relative Strength Index (RSI)
- CALC 47.92
- BGI 35.98
- Support Level
- CALC $1.61
- BGI $0.82
- Resistance Level
- CALC $1.73
- BGI $0.96
- Average True Range (ATR)
- CALC 0.10
- BGI 0.07
- MACD
- CALC -0.01
- BGI -0.00
- Stochastic Oscillator
- CALC 33.33
- BGI 4.95
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.